Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from TLX101-Tx and lomustine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

Question 4

What tests will I need to undergo, and how will they be done?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks I should be aware of before joining this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma clinical trial (NCT07100730). Contact the study team or your healthcare provider for specific answers.

What this study is about